The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

Killing on average over 100,000 children across the world per year, respiratory syncytial virus (RSV) is the second greatest cause of death by a single pathogen for children under one year of age ...

Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections worldwide, recently there has been a surge in interest in RSV antigens, antibodies, and more in ...

Respiratory syncytial virus is a common cause of acute respiratory infection in the pediatric population. Up to 70% of all infants acquire respiratory syncytial virus in the first 12 months. [1, 2 ...

Respiratory syncytial virus (RSV) affects infants, young children, and older adults, particularly those with compromised respiratory or cardiovascular health. Every year RSV causes approximately ...

Palivizumab, when given through the veins or into a muscle (systemically), reduces hospitalisations due to respiratory syncytial virus (RSV) and reduces respiratory problems later on (chest wheezing), ...

Respiratory syncytial virus is seen as a major cause of respiratory infections in adults. Patients who have recovered but have a weakened immune system may continue to be infectious for three to ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private ...

Respiratory syncytial virus (RSV) causes symptoms similar to the common cold. But in older adults and those with certain medical conditions, the virus can increase the risk of serious illnesses. A ...

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, ...